Burosumab-twza Subcutaneous and Peginterferon Alfa-2b (Peg-Intron)
Determining the interaction of Burosumab-twza Subcutaneous and Peginterferon Alfa-2b (Peg-Intron) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: peginterferon alfa-2b
Brand name: PegIntron, Sylatron, PegIntron Redipen
Synonyms: Peginterferon alfa-2b, Peginterferon Alfa-2b
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Peginterferon Alfa-2b (Sylatron)
- Burosumab-twza Subcutaneous-Peginterferon alfa-2b Subcutaneous
- Burosumab-twza Subcutaneous-Peginterferon beta-1a
- Burosumab-twza Subcutaneous-Peginterferon beta-1a Subcutaneous
- Burosumab-twza Subcutaneous-PegIntron
- Burosumab-twza Subcutaneous-Pegloticase
- Peginterferon Alfa-2b (Peg-Intron)-Buspar
- Peginterferon Alfa-2b (Peg-Intron)-Buspar Dividose
- Peginterferon Alfa-2b (Peg-Intron)-Buspirone
- Peginterferon Alfa-2b (Peg-Intron)-Buspirone Hydrochloride
- Peginterferon Alfa-2b (Peg-Intron)-Busulfan
- Peginterferon Alfa-2b (Peg-Intron)-Busulfan Concentrate Injection